Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
By Sahil Pandey Sept 2 (Reuters) - AI company Owkin said on Wednesday it has signed a licensing deal with Germany's Boehringer Ingelheim, giving the drugmake...
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Owkin"